Horizon Therapeutics Public Ltd Co

ORBIMED ADVISORS LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

266,400

Value ($000)

30,820

Weight

0.7%

2019 Q4 - 2023 Q3 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	30,820	0.7%	266,400	9/30/2023
2023 Q2	8/14/2023	32,542	0.6%	316,400	6/30/2023
2023 Q1	5/15/2023	21,828	0.4%	200,000	3/31/2023
2022 Q4	2/14/2023	19,460	0.4%	171,000	12/31/2022
2022 Q2	8/15/2022	168,178	3.1%	2,108,555	6/30/2022
2022 Q1	5/16/2022	231,100	3.8%	2,196,555	3/31/2022
2021 Q4	2/14/2022	269,406	3.5%	2,500,055	12/31/2021
2021 Q3	11/15/2021	285,938	3.2%	2,610,355	9/30/2021
2021 Q2	8/16/2021	273,631	2.8%	2,922,155	6/30/2021
2021 Q1	5/17/2021	289,406	2.8%	3,144,355	3/31/2021
2020 Q4	2/16/2021	220,090	1.9%	3,008,755	12/31/2020
2020 Q3	11/16/2020	233,720	3.0%	3,008,755	9/30/2020
2020 Q2	8/14/2020	159,398	2.3%	2,867,910	6/30/2020
2020 Q1	5/15/2020	69,361	1.2%	2,341,700	3/31/2020
2019 Q4	2/14/2020	57,279	0.8%	1,582,300	12/31/2019